Fast track — ArticlesInfluence of delay on survival in patients with breast cancer: a systematic review
Introduction
Detection and treatment of cancer at an early stage improves the prospects for long-term survival. In many types of cancer, the outlook for patients with small, localised tumours is much better than that of patients with advanced or metastatic disease. If cancers are diagnosed early, microscopic spread of disease may not have occurred. Excision of the primary tumour may therefore be curative. For some cancers, evidence shows that diagnosis and treatment before symptoms appear is associated with improved survival rates. The influence on survival of delays in diagnosis and treatment after onset of symptoms has, however, been much less clear.
Whether longer delays in patients who have symptoms are associated with worse outcomes cannot be studied in randomised controlled trials. Detailed analysis of observational data is therefore necessary, taking into account, wherever possible, potential confounding factors. Among patients with breast cancer, uncertainty persists about the possible impact of delays on survival, despite many different reports.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86 The question, however, remains important. Breast cancer is a common disease with more than 30 000 new cases per year in the UK.87, 88 Most (>75%) patients present after symptoms occur, rather than through the National Health Service breast-screening programme. In about a third of these patients, the time between the first symptom and start of treatment is more than 3 months89 and, in about a quarter of patients, more than 6 months.25, 43, 48, 51 Although age-standardised mortality ratios have fallen in the past decade90, 91, 92 breast cancer remains a major cause of death for women in the UK.
Our primary hypothesis was that longer delays between onset of symptoms and diagnosis or treatment are associated with worse survival rates in patients with breast cancer and that this association is not simply attributable to lead-time bias. We tested also a secondary hypothesis that patients with longer duration of symptoms would generally present with more advanced disease and that this relation between delay and stage would account for the poorer survival anticipated in patients with longer delays. These hypotheses were based on the findings from a study of patients attending the Guy's Hospital Breast Unit, London, UK,89 which we consequently excluded from this review.
This study forms part of a larger report commissioned by the National Health Service Cancer Research and Development Programme.93 A review of factors that influence delays by patients or providers is published in this issue of The Lancet (see page 1127).94
Section snippets
Data search
We did the review according to principles laid down to protect against bias.95, 96 Details of the methods are reported elsewhere, including the full search strategy and lists of all duplicate and excluded reports.93 We started the review in June, 1996, and completed it in March, 1998. We attempted to identify all observational studies (worldwide) related to women presenting with symptoms of breast cancer, with direct data linking duration of symptoms and survival. We did not limit the year of
Results
We identified 87 original studies that included information directly linking duration of symptoms (delay) and survival. The studies involved a total of 101 954 patients and were published between 1907 and 1996 (table 1). One report related to two separate studies of different cohorts.
Discussion
The combined results from each of the three categories support our primary hypothesis that longer delays are associated with worse survival rates. In category I the association between longer delay and worse survival was significant among studies with unrestricted samples and among those confined to patients with operable disease. In category II, 13 of 14 studies with unrestricted samples showed a significant adverse relation between longer delays and survival. Four of five studies confined to
References (103)
- et al.
Survival of female patients with cancer of the breast
Am J Surg
(1959) - et al.
A multivariate analysis of the contribution of “auxonometry” to prognosis in breast cancer
J Chronic Dis
(1979) - et al.
Delay, stage of disease and survival from breast cancer
J Chronic Dis
(1979) - et al.
Prognosis in inoperable stage III cancer of the breast
Eur J Cancer
(1977) - et al.
Delayed presentation in breast cancer: relationship to tumour stage and survival
Breast
(1993) Some factors influencing prognosis in breast cancer
J Fac Radiol
(1957)- et al.
Factors influencing the survival of patients with carcinoma of the breast
Am J Surg
(1963) - et al.
Factors predicting delayed presentation of symptomatic breast cancer: a systematic review
Lancet
(1999) - et al.
Carcinoma of the breast: end results, Massachusetts General Hospital, 1930, 1931 and 1932
Surg Gynecol Obstet
(1939) - et al.
Cancer of the breast
Ann Surg
(1941)
Carcinoma of the breast I: results of treatment
Ann Surg
Cancer of the breast: clinical study of 1042 cases treated at Radiumhemmet between 1936 and 1941
Acta Radiol Suppl
Carcinoma of the breast
Wisconsin Med J
Cancer of the breast: analysis of frequency, distribution and mortality at the University of California Hospital. 1918–1947 inclusive
Surg Gynecol Obstet
The relation between delay in treatment of cancer and survival rate
Br J Cancer
Carcinoma of the breast: 10 year survey at Winnipeg General Hospital
J Intl Coll Surg
Some observations concerned with carcinoma of the breast
Am J Roentgenol
The significance of delay in relation to prognosis of patients with primary operable breast cancer
Cancer
Statistical review of England and Wales for the year 1952 (supplement on Cancer)
A report of 549 cases of breast cancer in women 35 years of age or younger
Surg Gynecol Obstet
Cancer of the breast and biological predeterminism: a re-evaluation
Cancer
Taux d'accroissement et prognostic des tumeurs malignes du sein
Acta Union Intl Contra Cancrum
Prognosis of malignant tumours of the breast in relation to rate of growth and axillary lymph node involvement as observed clinically
Acta Union Intl Contra Cancrum
The influence of delay on the natural history and prognosis of breast cancer: a study of cases followed for 5–20 years
Surgery
The clinical stages of breast cancer: what do they mean?
Can Med Assoc J
The Registrar General's statistical review of England and Wales for the year 1961: supplement on cancer
Results of breast cancer treatment
Acta Chir Scand
The effects of delay in treatment on survival rates in carcinoma of the breast
Med J Aust
Observations and thoughts on cancer of the breast
Proc R Soc Med
Results of conservative operations for breast cancer
Arch Surg
The effects of behavioral and biological factors on survival from breast cancer
Cancer Detect Prev
Cancer of the breast: end results Massachusetts General Hospital, 1924, 1925 and 1926
N Engl J Med
Carcinoma of the breast: report of four hundred eighteen cases treated at St Luke's Hospital from 1922–1933
Surg Gynecol Obstet
The Halsted radical mastectomy: 5 year results in 246 consecutive operations at same clinic
Surgery
Evaluation of breast-cancer therapy as a guide to control programs
J Natl Cancer Inst
Carcinoma of the breast
Ann Surg
Carcinoma of the breast: III results of treatment 1935–1942
Ann Surg
Cancer of the breast: a review
Br J Radiol
Prognosis of mammary carcinoma in young women
Cancer
Carcinoma of the breast: extent of original disease related to end results
Arch Surg
Breast cancer in women thirty years old or less
N W Med Seattle
Prognosis of malignant tumours of the breast: a review of recent experiences of the Mayo clinic
Acta Union Intl Contra Cancrum
A 15 year follow-up study of patients treated for carcinoma of the breast
Br J Radiol
Delay in diagnosis and long term survival in breast cancer
BMJ
Symptom duration, tumor staging and survival in patients with carcinoma of the breast
Surg Gynecol Obstet
The effects of patient delay and symptoms other than a lump on survival in breast cancer
Cancer
Delay in the treatment of carcinoma of the breast
Surg Gynecol Obstet
Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer
Cancer
Breast self-examination and survival from breast cancer
Cancer
Cited by (951)
Invisible cancers: Seeing, knowing, enacting and proving cancers in Haiti
2024, Social Science and MedicinePerioperative genetic testing and time to surgery in patients with breast cancer
2024, Surgery (United States)Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, France
2023, Preventive Medicine Reports